Abbott Laboratories (Brazil) Top Management

ABTT34 Stock  BRL 61.26  2.04  3.22%   
Abbott Laboratories employs about 115 K people. The company is managed by 39 executives with a total tenure of roughly 340 years, averaging almost 8.0 years of service per executive, having 2948.72 employees per reported executive. Analysis of Abbott Laboratories' management performance can provide insight into the company performance.
Robert Ford  CEO
President, Chief Executive Officer, Chief Operating Officer, Director
Miles White  Chairman
Chairman, CEO and Chairman of Executive Committee
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Abbott Stock refer to our How to Trade Abbott Stock guide.

Abbott Laboratories Management Team Effectiveness

The company has return on total asset (ROA) of 0.0882 % which means that it generated a profit of $0.0882 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1928 %, meaning that it generated $0.1928 on every $100 dollars invested by stockholders. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.

Abbott Laboratories Workforce Comparison

Abbott Laboratories is number one stock in number of employees category among its peers. The total workforce of Medical Devices industry is presently estimated at about 340,291. Abbott Laboratories totals roughly 115,000 in number of employees claiming about 34% of all equities under Medical Devices industry.
The company has Profit Margin (PM) of 0.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2.

Abbott Laboratories Benchmark Summation

Operator
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was zero with a total number of output elements of sixty-one. Abbott Laboratories Price Series Subtraction is a subtraction of Abbott Laboratories price series from its benchmark/peer..

Abbott Laboratories Notable Stakeholders

An Abbott Laboratories stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Abbott Laboratories often face trade-offs trying to please all of them. Abbott Laboratories' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Abbott Laboratories' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Robert FordPresident, Chief Executive Officer, Chief Operating Officer, DirectorProfile
Miles WhiteChairman, CEO and Chairman of Executive CommitteeProfile
Jaime ContrerasSenior Vice President - Core Laboratory Diagnostics, Commercial OperationsProfile
Roger BirdSenior Vice President - U.S. NutritionProfile
Andrew LaneSenior Vice President - Established Pharmaceuticals, Emerging MarketsProfile
John CapekExecutive Vice President - VenturesProfile
Hubert AllenExecutive Vice President, General Counsel, SecretaryProfile
Joseph ManningSenior Vice President - Abbott Nutrition InternationalProfile
Jared WatkinSenior Vice President - Diabetes CareProfile
Robert FunckChief Financial Officer, Executive Vice President - FinanceProfile
Daniel SalvadoriSenior Vice President - Established Pharmaceuticals, Latin America.Profile
Samuel ScottIndependent DirectorProfile
Nancy McKinstryIndependent DirectorProfile
Phebe NovakovicIndependent DirectorProfile
Roxanne AustinIndependent DirectorProfile
Sally BlountIndependent DirectorProfile
Daniel StarksIndependent DirectorProfile
Michelle KumbierIndependent DirectorProfile
Robert AlpernIndependent DirectorProfile
Glenn TiltonIndependent DirectorProfile
Darren McDewIndependent DirectorProfile
Edward LiddyIndependent DirectorProfile
John StrattonIndependent DirectorProfile
William OsbornLead Independent DirectorProfile
Christopher ScogginsSenior Vice President - Rapid DiagnosticsProfile
Mary MorelandExecutive Vice President of Human ResourcesProfile
Michael DaleSenior Vice President - Structural HeartProfile
Sammy KaramSenior Vice President - Established Pharmaceuticals, Emerging MarketsProfile
Randel WoodgriftSenior Vice President - CRMProfile
Michael PedersonSenior Vice President - Electrophysiology and Heart FailureProfile
Lisa EarnhardtExecutive Vice President - Medical DevicesProfile
Alejandro WellischSenior Vice President - Established Pharmaceuticals, Latin AmericaProfile
Elaine LeavenworthVP OfficerProfile
Charles BrynelsenSenior Vice President - Abbott VascularProfile
Scott LeinenweberLicensing RelationsProfile
James YoungVP OfficerProfile
John GinascolExecutive Vice President - Core DiagnosticsProfile
Andrea WainerExecutive Vice President - Rapid and Molecular DiagnosticsProfile
Melissa BrotzVP MarketingProfile

About Abbott Laboratories Management Performance

The success or failure of an entity such as Abbott Laboratories often depends on how effective the management is. Abbott Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Abbott management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Abbott management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is based in North Chicago, Illinois. ABBOTT DRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 109000 people.
Please note, the presentation of Abbott Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Abbott Laboratories' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Abbott Laboratories' management manipulating its earnings.

Abbott Laboratories Workforce Analysis

Traditionally, organizations such as Abbott Laboratories use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Abbott Laboratories within its industry.

Abbott Laboratories Manpower Efficiency

Return on Abbott Laboratories Manpower

Revenue Per Employee379.6K
Revenue Per Executive1.1B
Net Income Per Employee60.3K
Net Income Per Executive177.8M

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings